Treinta y tres años de experiencias e investigación con levodopa y asociaciones en el tratamiento de la enfermedad de Parkinson

Chouza Antelo, Carlos E; Romero, S; Caamaño Valsangiacomo, José L; Aljanati Benedetto, Ruth E; Scaramelli Giordan, Alejandro; De Medina Massa, Ofrenda C; Buzo del Puerto, Ricardo M; Dieguez Yankauskas, Elen; Sanchez, N; Lorenzo Otero, Jorge L; Lisante, N; Marin, C; Gomensoro, J.
Arch. Inst. Neurol. (Montev., Impr.) ; 6(2): 45-53, 2003. ilus, tab, graf
Artículo en Español | LILACS | ID: lil-418923

Documentos relacionados

  1. Treinta y tres años de experiencias e investigación con levodopa y asociaciones en el tratamiento de la enfermedad de Parkinson
  2. Effectiveness and safety of safinamide in the Toledo Movement Disorders Unit.
  3. [Inhaled levodopa: from evidence to experience].
  4. Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities.
  5. [Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].
  6. Amantadine use in the French prospective NS-Park cohort.
  7. Time until modification of antiparkinsonian therapy in a group of patients from Colombia.
  8. Guess Who: dopamine agonist and creativity?
  9. Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man.
  10. Optimized clinical management of Parkinson's disease with opicapone. Recommendations from Spanish experts.